{
  "id": 15347150,
  "title": "Top pharma firms in new batch of strategic businesses",
  "url": "https://urgent.news/2026/10/18/top-pharma-firms-in-new-batch-of-strategic-businesses-15347150",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-18T03:17:18.000Z",
  "source": {
    "name": "RTHK English",
    "slug": "rthk-english",
    "url": "https://news.rthk.hk/rthk/en/component/k2/1874352-20261018.htm"
  },
  "original_language": "en",
  "account": null,
  "summary": "The director-general of the Office for Attracting Strategic Enterprises (Oases) on Sunday said the next batch of strategic enterprises would include top pharmaceutical companies, which would conduct clinical trials as well as medicinal research and development in Hong Kong. In total, Peter Yan said there would be around 10 to 20 firms in this intake, split evenly between mainland and overseas…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "RTHK News",
        "title": "Top pharma firms in new batch of strategic businesses",
        "url": "https://urgent.news/2026/10/18/top-pharma-firms-in-new-batch-of-strategic-businesses",
        "published": "2026-10-18T03:17:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}